Yahoo
OTC Markets OTCPK - Delayed Quote USD

Psykey, Inc. (CEOS)

0.0038 -0.0004 (-9.52%)
As of 11:24:11 AM EST. Market Open.
Chart Range Bar
Loading chart for CEOS
  • Previous Close 0.0042
  • Open 0.0038
  • Bid 0.0039 x 2000000
  • Ask 0.0048 x 14000000
  • Day's Range 0.0038 - 0.0038
  • 52 Week Range 0.0012 - 0.0090
  • Volume 60,000
  • Avg. Volume 86,777
  • Market Cap (intraday) 1.19M
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) --
  • EPS (TTM) -5.6900
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. The company was incorporated in 2002 and is based in Toronto, Canada.

www.psykeyworld.com

6

Full Time Employees

December 31

Fiscal Year Ends

Packaged Foods

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CEOS
29.25%
S&P 500 (^GSPC)
12.61%

1-Year Return

CEOS
32.14%
S&P 500 (^GSPC)
13.84%

3-Year Return

CEOS
70.06%
S&P 500 (^GSPC)
76.87%

5-Year Return

CEOS
93.46%
S&P 500 (^GSPC)
64.72%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -179.72%

  • Return on Equity (ttm)

    -726.10%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -5.01M

  • Diluted EPS (ttm)

    -5.6900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    57.42k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -474.98k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: